FDA Concerned Over Possible Hypersensitivity Linked to Addyi Side Effects
The FDA reports it is considering regulatory action following reports of hypersensitivity reactions to the female libido pill Addyi.
The FDA reports it is considering regulatory action following reports of hypersensitivity reactions to the female libido pill Addyi.
The findings of a new study warn that the health risks of the so-called "female Viagra" pill Addyi may outweigh it's benefits.
Public Citizen is predicting the FDA will eventually recall Addyi, being referred to as the "female Viagra" due to health risks and few benefits.